BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11113503)

  • 1. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.
    de la Torre JC; Stefano GB
    Brain Res Brain Res Rev; 2000 Dec; 34(3):119-36. PubMed ID: 11113503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease.
    de la Torre JC
    Ann N Y Acad Sci; 2000; 924():136-52. PubMed ID: 11193790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?
    de la Torre JC
    Ann N Y Acad Sci; 2000 Apr; 903():424-36. PubMed ID: 10818533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
    de la Torre JC
    Acta Neuropathol; 1999 Jul; 98(1):1-8. PubMed ID: 10412794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis.
    de la Torre JC
    Neurobiol Aging; 2000; 21(2):331-42. PubMed ID: 10867218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease.
    de la Torre JC
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S72-81. PubMed ID: 10850734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular basis of Alzheimer's pathogenesis.
    de la Torre JC
    Ann N Y Acad Sci; 2002 Nov; 977():196-215. PubMed ID: 12480752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovasculature-mediated neuronal cell death.
    Grammas P; Reimann-Philipp U; Weigel PH
    Ann N Y Acad Sci; 2000 Apr; 903():55-60. PubMed ID: 10818489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease.
    Toda N; Okamura T
    J Pharmacol Sci; 2016 Aug; 131(4):223-32. PubMed ID: 27530818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow regulation by nitric oxide in Alzheimer's disease.
    Toda N; Okamura T
    J Alzheimers Dis; 2012; 32(3):569-78. PubMed ID: 22810094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.
    Donahue JE; Berzin TM; Rafii MS; Glass DJ; Yancopoulos GD; Fallon JR; Stopa EG
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6468-72. PubMed ID: 10339611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.
    Kalaria RN
    Ann N Y Acad Sci; 1999; 893():113-25. PubMed ID: 10672233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats.
    de la Torre JC; Pappas BA; Prevot V; Emmerling MR; Mantione K; Fortin T; Watson MD; Stefano GB
    Neurol Res; 2003 Sep; 25(6):635-41. PubMed ID: 14503018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral microvascular pathology in aging and Alzheimer's disease.
    Farkas E; Luiten PG
    Prog Neurobiol; 2001 Aug; 64(6):575-611. PubMed ID: 11311463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
    de la Torre JC
    J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
    de la Torre JC
    Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor.
    Stefano GB; Goumon Y; Bilfinger TV; Welters ID; Cadet P
    Prog Neurobiol; 2000 Apr; 60(6):513-30. PubMed ID: 10739087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
    Lourenço CF; Ledo A; Barbosa RM; Laranjinha J
    Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.